6,9-Diazaspiro[4.5]decane-9-acetic acid, 8-(3,5-difluorophenyl)-10-oxo-, (8R)-
6,9-Diazaspiro[4.5]decane-9-acetic acid, 8-(3,5-difluorophenyl)-10-oxo-, (8R)-(957187-34-7)
- Name: 6,9-Diazaspiro[4.5]decane-9-acetic acid, 8-(3,5-difluorophenyl)-10-oxo-, (8R)-
- Synonyms:6,9-DIAZASPIRO[4.5]DECANE-9-ACETIC ACID, 8-(3,5-DIFLUOROPHENYL)-10-OXO-, (8R)-;
- Molecular Formula:C16H18F2N2O3
- Molecular Weight:324.327
- CAS Registry Number:957187-34-7
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.957187-34-7 6,9-Diazaspiro[4.5]decane-9-acetic acid, 8-(3,5-difluorophenyl)-10-oxo-, (8R)-
Assay:98%Min Appearance:detailed see specifications Package:according to the clients requirement Storage:Store in dry, dark and ventilated place. Transportation:by ocean shipping or clients requirement Application:An important raw material and intermediate used in Organic Synthesis, Pharmaceuticals
Min. Order:0
Supplier:Dayang Chem (Hangzhou) Co.,Ltd. [
China (Mainland)] 
Assessed
SupplierTel:+86-571-88938639
Address:9/F, Unit 2 Changdi Torch Building, 259# WenSan Road, Xihu District, Hangzhou City 310012, P.R.China
- Contact Suppliers
CAS No.957187-34-7 Hot productCAS 957187-34-7 with best price
Assay:99% Appearance:White powder Package: [Packaging]20mg, 50mg,100mg,1g,10g,100g,according to customers' requirements Storage: should be stored in a well-closed container at low temperature, keep away from moisture, heat and light. Transportation:1. Samples 1kg-10kg are shipped by international express. 2. 50kg-100kg of goods are transported by dedicated line logistics. 3. Cargo 100kg-1ton is transported by dedicated line logistics. Application:Raw materials in the pharmaceutical field
Min. Order:10Kilogram
Supplier:Zhuozhou Wenxi import and Export Co., Ltd [
China (Mainland)] 
Premium
SupplierTel:+86-13111626072
Address:Room 1710, Baoxin International Phase I, 19 Guanyun East Road, Zhuozhou, Hebei
- Contact Suppliers
Other Product
- 912445-36-4/1H-Benzimidazole-7-carboxamide, 2-[(2S)-2-methyl-2-pyrrolidinyl]-, hydrochloride (1:2)
- 952490-01-6/Propanoic acid, 2,2-dimethyl-, 4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl ester
- 948846-40-0/Butanedioic acid, 2,3-bis(benzoyloxy)-, (2S,3S)-, coMpd. with ethyl (3aR,6aR)-hexahydropyrrolo[3,4-b]pyrrole-5(1H)-carboxylate (1:)
- 1000164-36-2/Alanine, N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-glutaminyl-L-alanyl-L-alanyl-N6-[(1,1-dimethylethoxy)carbonyl]-L-lysyl-L-α-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-1-[(1,1-dimethylethoxy)carbonyl]-L-tryptophyl-L-leucyl-L-valyl-N6-[(1,1-dimethylethoxy)carbonyl]-L-lysyl-2-methyl-, 5-(1,1-dimethylethyl) ester
- 813452-14-1/2-Pyrrolidinone, 1-[(2S,3S,11bS)-2-amino-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-2H-benzo[a]quinolizin-3-yl]-4-(fluoromethyl)-, hydrochloride (1:2), (4S)-
- 941685-39-8/1H-Pyrazole-1-propanenitrile, β-cyclopentyl-4-[7-[[2-(trimethylsilyl)ethoxy]methyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-
- 586414-48-4/Benzamide, 3-[3-bromo-4-[(2,4-difluorophenyl)methoxy]-6-methyl-2-oxo-1(2H)-pyridinyl]-N,4-dimethyl-, (-)-
- 540737-29-9/Tofacitinib citrate
- 1137917-12-4/Benzoic acid, 3-[[6-(ethylsulfonyl)-3-pyridinyl]oxy]-5-[(1S)-2-hydroxy-1-methylethoxy]-, compd. with 1,4-diazabicyclo[2.2.2]octane (2:1)
- 475578-12-2/1,3-Bis(2-methylphenyl)-1H-imidazolium chloride
- 475578-18-8/4,5-Dihydro-1,3-bis(2-methylphenyl)-1H-imidazolium chloride
- 1032066-96-8/6H-Purin-6-one, 2-amino-9-[(1S,3R,4S)-4-(dimethylphenylsilyl)-2-methylene-3-[(phenylmethoxy)methyl]cyclopentyl]-1,9-dihydro-, methanesulfonate (2:1)
- 134388-95-7/2,3(1H)-Isoquinolinedicarboxylic acid, octahydro-6-oxo-, 2-methyl ester, [3S-(3α,4aα,8aα)]-, compd. with (R)-α-methylbenzenemethanamine (1:1) (9CI)
- 356058-42-9/1H-Cyclopentapyrimidine-1-acetic acid, 2-[[(4-fluorophenyl)methyl]thio]-4,5,6,7-tetrahydro-4-oxo-
- 451487-18-6/4H-Cyclopentapyrimidin-4-one, 2-[[(4-fluorophenyl)methyl]thio]-1,5,6,7-tetrahydro- (9CI)
- 868210-14-4/Butanoic acid, 4-[4-[[(2S,4R)-4-[acetyl(4-chlorophenyl)amino]-3,4-dihydro-2-methyl-1(2H)-quinolinyl]carbonyl]phenoxy]-2,2-dimethyl-
- 934815-71-1/Benzeneacetic acid, 3-[6-[[2-(2,4-dichlorophenyl)ethyl]amino]-2-methoxy-4-pyrimidinyl]-α,α-dimethyl-, phosphate (1:1)
- 941685-40-1/1H-Pyrazole-1-propanenitrile, β-cyclopentyl-4-[7-[[2-(trimethylsilyl)ethoxy]methyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-, (βR)-
- 941685-41-2/1H-Pyrazole-1-propanenitrile, β-cyclopentyl-4-[7-[[2-(trimethylsilyl)ethoxy]methyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-, (βS)-
- 957187-34-7/6,9-Diazaspiro[4.5]decane-9-acetic acid, 8-(3,5-difluorophenyl)-10-oxo-, (8R)-
- 503290-66-2/3-Isoquinolinecarboxylic acid, 6-[3-chloro-2-(2H-tetrazol-5-yl)phenoxy]decahydro-, hydrochloride (1:1), (3S,4aS,6S,8aR)-
- 127815-09-2/5H-Inden-5-one, 1-(1,1-dimethylethoxy)octahydro-7a-methyl-4-(3-oxopentyl)-, [1S-(1α,3aβ,4β,7aα)]- (9CI)
- 41878-38-0/5H-Inden-5-one, 1-(1,1-dimethylethoxy)-1,2,3,6,7,7a-hexahydro-7a-methyl-, (1S,7aS)-
- 503291-53-0/3-Isoquinolinecarboxylic acid, 6-[3-chloro-2-(1H-tetrazol-5-yl)phenoxy]decahydro-, 2-ethylbutyl ester, (3S,4aS,6S,8aR)-, mono(4-methylbenzenesulfonate) (9CI)
- 10072-75-0/1H-Benz[e]indene-3,7(2H,3aH)-dione, 4,5,8,9,9a,9b-hexahydro-3a,6-dimethyl-, (3aS,9aS,9bS)-
- 503293-98-9/2,3(1H)-Isoquinolinedicarboxylic acid, octahydro-6-hydroxy-, 2-methyl ester, (3S,4aS,6S,8aR)-
- 550349-58-1/3H-Pyridazino[4,5-b]indole-1-carboxamide, 7-chloro-4,5-dihydro-3-(6-methoxy-3-pyridinyl)-N,N,5-trimethyl-4-oxo-
- 272776-12-2/[1,1'-Binaphthalene]-2,2'-diol, (1S)-, compd. with 5-methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole (1:1)
- 370882-57-8/Pyrrolo[3,4-b]pyrrole, octahydro-1-(3-pyridinyl)-, hydrochloride (1:2), (3aS,6aS)-
- 871022-14-9/Cyclobutanecarboxylic acid, 1-[[4-[[[[2,3-dihydro-3-(1-methylethyl)-2-oxo-1H-benzimidazol-1-yl]carbonyl]amino]methyl]-1-piperidinyl]methyl]-